| Nivolumab in Combination With GDP/ L-asparaginase in NK/ T-cell Lymphoma (NCT04230330) | National Cancer Centre, Singapore | 2019-12-12 |
| Safety and Tolerability of SYNB1891 Injection Alone or in Combination With Atezolizumab in Adult Participants (NCT04167137) | Synlogic | 2019-12-12 |
| A Study of Modakafusp Alfa (TAK-573) Given by Itself and Together With Pembrolizumab in Adults With Advanced or Metastatic Solid Tumors (NCT04157517) | Teva Branded Pharmaceutical Products R&D LLC | 2019-12-12 |
| A Phase I Study to Assess the Effect of Itraconazole and Rifampicin on Pharmacokinetics Profile of BPI-7711 (NCT04135833) | Beta Pharma, Inc. | 2019-12-12 |
| A Study of LY3526318 in Healthy Women (NCT04183283) | Eli Lilly and Company | 2019-12-12 |
| A Clinical Trial Evaluating TG4050 in Head and Neck Cancer (NCT04183166) | Transgene | 2019-12-12 |
| 68Ga-PSMA-11 PET for the Diagnosis of Biochemically Recurrent Prostate Cancer (NCT04216134) | City of Hope Medical Center | 2019-12-12 |
| L-DOS47 Plus Doxorubicin in Advanced Pancreatic Cancer (NCT04203641) | Helix BioPharma Corporation | 2019-12-11 |
| Single Ascending Dose Study of CTI-1601 Versus Placebo in Subjects With Friedreich's Ataxia (NCT04176991) | Larimar Therapeutics, Inc. | 2019-12-11 |
| Treg Modulation With CD28 and IL-6 Receptor Antagonists (NCT04066114) | National Institute of Allergy and Infectious Diseases (NIAID) | 2019-12-11 |
| Safety and Pharmacokinetic Study of Tenofovir Alafenamide (TAF)/Elvitegravir (EVG) Administered Rectally (NCT04047420) | National Institute of Allergy and Infectious Diseases (NIAID) | 2019-12-11 |
| PET/CT Imaging of Small Cell Lung Cancer Using 89Zr-DFO-SC16.56 (NCT04199741) | Memorial Sloan Kettering Cancer Center | 2019-12-11 |
| KD025 Hepatic Impairment Study With Normal Hepatic Function and Subjects With Varying Degrees of Hepatic Impairment (NCT04166942) | Kadmon, a Sanofi Company | 2019-12-11 |
| Study of B7-H3-Specific CAR T Cell Locoregional Immunotherapy for Diffuse Intrinsic Pontine Glioma/Diffuse Midline Glioma and Recurrent or Refractory Pediatric Central Nervous System Tumors (NCT04185038) | Seattle Children's Hospital | 2019-12-11 |
| A Phase 1/2 Study in Patients With HPV16+ Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma and Other Cancers (NCT04180215) | Hookipa Biotech GmbH | 2019-12-11 |
| TAS-102 With Concurrent Radiation for the Treatment of Untreated Resectable Stage II-III Rectal Cancer (NCT04104139) | OHSU Knight Cancer Institute | 2019-12-11 |
| Phase Ib Study to Assess Safety and Preliminary Efficacy of Tafasitamab or Tafasitamab Plus Lenalidomide in Addition to R-CHOP in Patients With Newly Diagnosed DLBCL (NCT04134936) | MorphoSys AG | 2019-12-11 |
| A Study in People With Normal Kidney Function and People With Reduced Kidney Function to Test How BI 764198 is Processed in the Body (NCT04176536) | Boehringer Ingelheim | 2019-12-10 |
| A Study of the Safety of REN001 in Patients With McArdle Disease (NCT04226274) | Reneo Pharma Ltd | 2019-12-10 |
| Clinical Study to Assess the Safety and Preliminary Efficacy of HCR040 in Acute Respiratory Distress Syndrome (NCT04289194) | Histocell, S.L. | 2019-12-10 |
| Bosutinib in Combination With Pemetrexed in Patients With Selected Metastatic Solid Tumors (NCT03023319) | Nagla Abdel Karim | 2019-12-10 |
| A Study in Subjects With Advanced Solid Tumors (NCT04156100) | Agenus Inc. | 2019-12-10 |
| Safety and Tolerability of Lu AF95245 in Healthy Young Men (NCT04199585) | H. Lundbeck A/S | 2019-12-10 |
| Bioequivalence Study of Two Dabigatran Etexilate Mesylate Capsules in Healthy Subjects (NCT06876623) | The Affiliated Hospital Of Guizhou Medical University | 2019-12-10 |
| CTA101 UCAR-T Cell Injection for Treatment of Relapsed or Refractory CD19+ B-cell Acute Lymphoblastic Leukemia (NCT04154709) | Kai Lin Xu; Jun Nian Zheng | 2019-12-10 |
| A Study Evaluating the Bioavailability of Oral Insulin (N11005) (NCT04975022) | Beijing Hospital | 2019-12-10 |
| A Study of LY3484356 in Participants With Advanced or Metastatic Breast Cancer or Endometrial Cancer (NCT04188548) | Eli Lilly and Company | 2019-12-10 |
| Pharmacokinetic Profile of Glepaglutide After a Single Injection in Subjects With Varying Degrees of Renal Function (NCT04178447) | Zealand Pharma | 2019-12-10 |
| Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist) (NCT04198766) | Inhibrx Biosciences, Inc | 2019-12-10 |
| Mass Balance Recovery, Metabolite Profile and Metabolite Identification of [14C]-MD1003 in Healthy Male Subjects (NCT04223232) | MedDay Pharmaceuticals SA | 2019-12-10 |
| Longitudinal Immune-phenotyping of HCC Following MK-3475 (NCT04224480) | National Cancer Centre, Singapore | 2019-12-10 |
| A Trial Evaluating TG4050 in Ovarian Carcinoma. (NCT03839524) | Transgene | 2019-12-09 |
| Testing the Combination of Anetumab Ravtansine With Either Nivolumab, Nivolumab and Ipilimumab, or Gemcitabine and Nivolumab in Advanced Pancreatic Cancer (NCT03816358) | National Cancer Institute (NCI) | 2019-12-09 |
| A Study to Evaluate the Safety and Tolerability of RO7296682 in Participants With Advanced Solid Tumors (NCT04158583) | Hoffmann-La Roche | 2019-12-09 |
| A Study of Belantamab Mafodotin to Investigate Safety, Tolerability, Pharmacokinetics, Immunogenicity and Clinical Activity in Participants With Relapsed/Refractory Multiple Myeloma (RRMM) (NCT04177823) | GlaxoSmithKline | 2019-12-09 |
| A Study of Pembrolizumab in Combination With Cisplatin and Pemetrexed in Advanced Malignant Pleural Mesothelioma (MPM) (MK-3475-A17) (NCT04153565) | Merck Sharp & Dohme LLC | 2019-12-09 |
| Safety, Tolerability, and Pharmacokinetics of Oral EC5026 in Healthy Subjects (NCT04228302) | EicOsis Human Health Inc. | 2019-12-09 |
| Ciprofloxacin/Celecoxib Combination in Patients With ALS (NCT04090684) | NeuroSense Therapeutics Ltd. | 2019-12-09 |
| Assessing the Pharmacokinetics Effects of Food on ASK120067 in Single Oral Administration in Chinese Healthy Subjects (NCT04360915) | Jiangsu Aosaikang Pharmaceutical Co., Ltd. | 2019-12-09 |
| Temporary Celiac Ganglion Block as a Test Before Celiac Ganglion Resection for Dysautonomia-Related Bowel Dysmotility (NCT04121338) | Johns Hopkins University | 2019-12-09 |
| Generic Plerixafor Efficacy of Autologous Hematopoietic Stem Cell Transplantation (NCT06892119) | Hospital Universitario Dr. Jose E. Gonzalez | 2019-12-09 |
| Apixaban in Subjects With Peritoneal Dialysis (NCT04006093) | University Hospital, Caen | 2019-12-08 |
| Evaluation of the Safety, Tolerability and Pharmacokinetics of Intravenous FL058 Administered in Healthy Subjects(SAD) (NCT05058118) | Qilu Pharmaceutical Co., Ltd. | 2019-12-08 |
| Low Dose of Cannabidiol (CBD) to Treat Mild to Moderate Musculoskeletal Pain (NCT04193631) | Pure Green | 2019-12-07 |
| Bioavailability of Dienogest 2.0 mg With Regards to Reference Product (NCT04230083) | Laboratorios Andromaco S.A. | 2019-12-07 |
| Chemokine Modulation Therapy and Standard Chemotherapy Before Surgery for the Treatment of Early Stage Triple Negative Breast Cancer (NCT04081389) | Roswell Park Cancer Institute | 2019-12-06 |
| A First-in-Human Study of Single and Multiple Doses of anle138b in Healthy Subjects (NCT04208152) | MODAG GmbH | 2019-12-06 |
| CTx-1301 Comparative Bioavailability Study (NCT04138498) | Cingulate Therapeutics | 2019-12-06 |
| A Phase 1/Phase 2 Study of Polyvalent Pneumococcal Conjugate Vaccine (V116) in Adults (V116-001) (NCT04168190) | Merck Sharp & Dohme LLC | 2019-12-06 |
| Paclitaxel for the Treatment of Gastric or Gastroesophageal Cancer (NCT04220827) | M.D. Anderson Cancer Center | 2019-12-06 |
| GDC-0084 With Radiation Therapy for People With PIK3CA-Mutated Solid Tumor Brain Metastases or Leptomeningeal Metastases (NCT04192981) | Memorial Sloan Kettering Cancer Center | 2019-12-06 |
| Determining Dose of Regadenoson Most Likely to Transiently Alter the Integrity of the Blood-Brain Barrier in Patients With High Grade Gliomas (NCT03971734) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2019-12-06 |
| Study of TPX-0046, A RET/SRC Inhibitor in Adult Subjects With Advanced Solid Tumors Harboring RET Fusions or Mutations (NCT04161391) | Turning Point Therapeutics, Inc. | 2019-12-06 |
| A Study to Evaluate the Safety, Tolerability, Drug Levels and Drug Effects of Single and Multiple Doses of BMS-986209 in Healthy Participants (NCT04154800) | Bristol-Myers Squibb | 2019-12-06 |
| Phase 1 Study of PK and Safety of Tebipenem Pivoxil Hydrobromide (TBPM-PI-HBr) in Subjects With Various Degrees Of Renal Function (NCT04178577) | Spero Therapeutics | 2019-12-06 |
| A Comparative Study of New Formulation and Approved Formulation for Levothyroxine in Healthy Volunteers (NCT03979274) | Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany | 2019-12-06 |
| Fecal Microbiota Transplant (FMT) Capsule for Improving the Efficacy of Anti- PD-1 (NCT04130763) | Peking University | 2019-12-05 |
| The Effect of Rifampicin on the Pharmacokinetics of Intracellular Tenofovir-diphosphate and Tenofovir When Coadministered With Tenofovir Alafenamide Fumarate During the Maintenance Phase of Tuberculosis Treatment in TB/HIV-1 Coinfected Participants (NCT04424264) | Professor Francois Venter | 2019-12-05 |
| Study of Oral Rucaparib With Other Anticancer Agents in Metastatic Castration Resistant Prostate Cancer Patients (RAMP) (NCT04179396) | pharmaand GmbH | 2019-12-05 |
| Safety, Tolerability, Pharmacokinetics, Pharmacodynamics of GSK2330811 in Healthy Japanese Participants (NCT04138043) | GlaxoSmithKline | 2019-12-05 |
| Mesenchymal Stem Cells for The Treatment of Acute Ischemic Stroke (NCT04097652) | Meridigen Biotech Co., Ltd. | 2019-12-05 |
| Pancreatic Islet Transplantation Into the Anterior Chamber of the Eye (NCT02846571) | Midhat H. Abdulreda | 2019-12-05 |
| A Study of LY3200882 and Pembrolizumab in Participants With Advanced Cancer (NCT04158700) | Eli Lilly and Company | 2019-12-05 |
| A Biopharmaceutics Study to Assess the Pharmacokinetics of Single Oral and IV Doses of Olorofim (NCT04207957) | F2G Ltd | 2019-12-05 |
| Effect of a Ghrelin Receptor Agonist on Muscle and Bone (NCT04021706) | Tufts University | 2019-12-05 |
| A Study of WVT078 in Patients With Multiple Myeloma (MM) (NCT04123418) | Novartis Pharmaceuticals | 2019-12-05 |
| A Study of Combination Caplet With Loperamide Hydrochloride and Simethicone, and Imodium Express Tablets-lyophilizate Coadministered With Espumisan Capsule in Healthy Volunteers (NCT04186936) | McNeil AB | 2019-12-05 |
| ADME Study of [14C]-Ibrexafungerp in Healthy Male Subjects (NCT04307082) | Scynexis, Inc. | 2019-12-05 |
| A Study of HY209 in Healthy Male Volunteers for Sepsis (NCT04255979) | Shaperon | 2019-12-05 |
| A Study to Evaluate the Pharmacokinetics and Safety of ASP015K in Healthy Chinese Subjects (NCT04143477) | Astellas Pharma China, Inc. | 2019-12-05 |
| A Study Evaluating the Safety, Tolerability, and Initial Efficacy of IBI110 in Subjects With Advanced Malignant Tumors (NCT04085185) | Innovent Biologics (Suzhou) Co. Ltd. | 2019-12-04 |
| Safety Study of BJ-001, an IL-15 Fusion Protein, for Locally Advanced/Metastatic Solid Tumors (NCT04294576) | BJ Bioscience, Inc. | 2019-12-04 |
| Single Fraction Stereotactic Body Radiation Therapy After Surgery in Treating Patients With Non-small Cell Lung Cancer (NCT04073745) | Roswell Park Cancer Institute | 2019-12-04 |
| Safety and Pharmacokinetics of Rezafungin (NCT04117607) | National Institute of Allergy and Infectious Diseases (NIAID) | 2019-12-04 |
| PHP and Immunotherapy in Metastasized UM (NCT04283890) | Leiden University Medical Center | 2019-12-04 |
| Study Evaluating the Safety, Efficacy and Pharmacokinetics of CA-008 (Vocacapsaicin) (NCT04203537) | Concentric Analgesics | 2019-12-04 |
| Double-blind, Placebo-control, Study to Evaluate the Safety and Pharmacokinetics of CT-044 HCl, in Healthy Volunteers (NCT04175743) | Lotus Clinical Research, LLC | 2019-12-04 |
| A Study of LY3471851 in Participants With Eczema (NCT04081350) | Nektar Therapeutics | 2019-12-04 |
| BM-MNCs for Lower Extremity Compartment Syndrome Injury (NCT03880656) | Oregon Health and Science University | 2019-12-04 |
| A Study of Mirikizumab in Healthy Chinese Participants (NCT04137380) | Eli Lilly and Company | 2019-12-04 |
| AVB-S6-500 and Durvalumab in Treating Patients With Platinum-Resistant or Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer (NCT04019288) | M.D. Anderson Cancer Center | 2019-12-03 |
| Social Decision Making in Parkinson's Disease (NCT04249544) | Vanderbilt University Medical Center | 2019-12-03 |
| Safety and Immunogenicity Following Recombinant Hepatitis B (Bio Farma) Vaccine in Adults & Children (NCT04188223) | PT Bio Farma | 2019-12-03 |
| Mapping Draining Lymph Nodes in CNS Malignancies (NCT04096716) | Washington University School of Medicine | 2019-12-03 |
| An Open, Randomised, Single Dose, 2-period, 2-sequence Crossover Adhesion Study of Two Different Transdermal Patches Containing Rotigotine. (NCT04183634) | Sandoz | 2019-12-03 |
| Glasdegib for Chronic Graft-Versus-Host Disease (NCT04111497) | Fred Hutchinson Cancer Center | 2019-12-03 |
| A Study to Evaluate the Drug-drug Interaction Effect of Itraconazole on the Pharmacokinetics (PK) of AMG 510 in Healthy Participants (NCT05568082) | Amgen | 2019-12-03 |
| Allogeneic NK Cell ("SMT-NK") in Combination With Pembrolizumab in Advanced Biliary Tract Cancer (NCT03937895) | SMT bio Co., Ltd. | 2019-12-03 |
| Phase 1 Study in Patients With Advanced Solid Malignancies to Evaluate the Safety of ATOR-1017 (NCT04144842) | Alligator Bioscience AB | 2019-12-03 |
| A Study in Leukemia Patients With Karonudib (NCT04077307) | Thomas Helleday Foundation | 2019-12-03 |
| Safety and Efficacy of a Hepatitis B Vaccine in Immunosuppressed Patients (NCT04199715) | Baylor Research Institute | 2019-12-03 |
| A Study to Test the Safety and Tolerability of UCB0107 in Study Participants With Progressive Supranuclear Palsy (PSP) (NCT04185415) | UCB Biopharma SRL | 2019-12-03 |
| Clinical Trial of Human (Allogeneic) iPS Cell-derived Cardiomyocytes Sheet for Ischemic Cardiomyopathy (NCT04696328) | Osaka University | 2019-12-02 |
| A Phase 1b Master Trial to Investigate CPX-351 in Subjects With Previously Untreated Acute Myeloid Leukemia (NCT04075747) | Jazz Pharmaceuticals | 2019-12-02 |
| Bioequivalence of Solid/Crushed/Dissolved Forms of Biktarvy® (NCT04244448) | University Hospital, Caen | 2019-12-02 |
| Sentinel Lymph Node Navigation Surgery Using Near-infrared Imaging in Early Esophageal Cancer (NCT04173676) | Fifth Affiliated Hospital, Sun Yat-Sen University | 2019-12-02 |
| Safety and Immunogenicity of CJ-40010 in Healthy Subjects (NCT04182932) | HK inno.N Corporation | 2019-12-02 |
| Irritation and Sensitization Study of d-Amphetamine Transdermal System (NCT04094025) | Noven Therapeutics | 2019-12-02 |
| Exploratory Study of NS-089/NCNP-02 in DMD (NCT04129294) | National Center of Neurology and Psychiatry, Japan | 2019-12-02 |
| An Open Label Study to Evaluate the Impact of Duration of Subcutaneous Infusion of a Novel, pH Neutral Formulation of Furosemide (Furoscix®) on Safety and Local Skin Tolerability (NCT04161482) | scPharmaceuticals, Inc. | 2019-12-02 |